Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 945 across all filing types
Latest filing 2024-10-18 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Issue of Duplicate Share Certificate
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issuance of a Letter of Confirmation in lieu of lost/misplaced share certificates. It references SEBI regulations and provides details of shareholders and shares involved. The content is an official notification about share certificate replacement, not a financial report, earnings release, or management discussion. It does not contain financial data or results, nor is it a report or presentation. It is a regulatory compliance communication related to shareholding records. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-18 English
Board Meeting — NEULAND LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company…
Regulatory Filings
2024-10-17 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from Neuland Laboratories Limited to stock exchanges about an upcoming Board Meeting scheduled for November 6, 2024. The purpose of the meeting is to approve and take on record the unaudited financial results for the quarter and half year ended September 30, 2024. The document also mentions the closure of the trading window in accordance with the Insider Trading Code. The document is short (1497 characters) and serves as an announcement of a future event (Board Meeting) rather than containing any financial data or results itself. It does not contain actual financial statements or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement informing the market about the Board Meeting and related compliance matters, not the financial report itself or a detailed management report.
2024-10-17 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying recent media/social media news about export data and its relation to the company's financials. It references management commentary from a previous earnings call but does not contain any financial statements, detailed financial data, or report content. The document is short (1316 characters) and serves as a clarification or regulatory communication rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2024. It is addressed to stock exchanges and certifies that details of securities dematerialized/rematerialized have been furnished as required. The document is short (3159 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report publication but a compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and certifications that do not fit other specific categories.
2024-10-15 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Legal Proceedings Report Classification · 95% confidence The document is an update letter addressed to stock exchanges (BSE and NSE) regarding a previously disclosed public interest litigation (PIL) involving the company. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to continuous disclosure obligations for listed companies. The content provides an update on the status of litigation, which is a regulatory announcement about a legal proceeding. The document is relatively short (3520 characters) and does not contain financial statements or detailed financial analysis. It is not a full audit report or annual report but an update on a legal matter. Therefore, it fits best under the category of Legal Proceedings Report (LTR).
2024-10-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.